Mrs Lisa Gayle Smith, MS, CCC-SLP in Brooklyn, MS - Speech-Language Pathologist

Mrs Lisa Gayle Smith, MS, CCC-SLP is a Speech-language Pathologist based in Brooklyn, Mississippi. Mrs Lisa Gayle Smith is licensed to practice in Mississippi (license number 12104093) and her current practice location is 130 Sam Boyte Rd, Brooklyn, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 818-5508.

NPI number for Mrs Lisa Gayle Smith is 1477884674 and her current mailing address is 130 Sam Boyte Rd, Brooklyn, Mississippi. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1477884674.

Contact Information

	Mrs Lisa Gayle Smith, MS, CCC-SLP
	130 Sam Boyte Rd, Brooklyn, MS 39425-9501
	(601) 818-5508
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Lisa Gayle Smith
Gender	Female
Speciality	Speech-language Pathologist
Location	130 Sam Boyte Rd, Brooklyn, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1477884674
Provider Enumeration Date: 01/27/2010
Last Update Date: 01/27/2010

Medical Identifiers

Medical identifiers for Mrs Lisa Gayle Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477884674	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	12104093 (Mississippi)	Primary
235Z00000X	Speech-language Pathologist	S3064 (Mississippi)	Secondary
235Z00000X	Speech-language Pathologist	193758 (Mississippi)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Lisa Gayle Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Lisa Gayle Smith, MS, CCC-SLP 130 Sam Boyte Rd, Brooklyn, MS 39425-9501 Ph: (601) 818-5508	Mrs Lisa Gayle Smith, MS, CCC-SLP 130 Sam Boyte Rd, Brooklyn, MS 39425-9501 Ph: (601) 818-5508

News Archive

Education may help increase awareness of HPV risk and vaccination rates in college-age men

Male collegiate athletes have high rates of risk factors for infection with the cancer-causing human papillomavirus (HPV), but have low HPV vaccination rates and low awareness of their personal health risks, according to a study in the November issue of The Nurse Practitioner, published by Wolters Kluwer.

U-M startup offers free coronavirus sequencing kits for researchers

As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples.

Transcat announces acquisition of Newark's calibration services business

Transcat, Inc., a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other measurement services, announced today that it has acquired the calibration services business from Newark, a subsidiary of Premier Farnell, PLC, and entered into a strategic alliance whereby Newark will market Transcat's calibration services to its broad customer base of electronic design engineers, maintenance, repair and operations engineers, and industrial buyers.

The AFA to acknowledge use of media in family building, infertility

The American Fertility Association, a 501 (c)(3) national non-profit organization, will recognize the media's role in family building and infertility. Illuminations - an event celebrating the accomplishments of individuals and organizations who have made a positive impact in the fields of reproductive health, family building and fertility - is coming to New York City.

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.

Mrs Lisa Gayle Smith, MS, CCC-SLP - Speech-Language Pathologist in Brooklyn, MS